Stephanie Wong
VP, Finance and Controller, SciClone Pharmaceuticals (United States).
Companies
- AN2 Therapeutics, Inc.Board member Mar 24, 2022 to now1
- Calithera Biosciences, Inc.VP, FINANCE Jan 6, 2017 to Jan 25, 20232
- SciClone Pharmaceuticals (United States)VP, Finance and Controller Aug 10, 2012 to Apr 8, 20133
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Calithera Biosciences, Inc.6,647 shares4Jan 25, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 23, 2023Shares withheld for tax 317 shares at $0.45 of Calithera Biosciences, Inc.4
- Jan 21, 2022Shares withheld for tax 5,586 shares at $0.49 of Calithera Biosciences, Inc.5
- Jan 4, 2022Shares withheld for tax 18,077 shares at $0.66 of Calithera Biosciences, Inc.6
- Nov 8, 2021Shares withheld for tax 15,566 shares at $0.87 of Calithera Biosciences, Inc.7
- Nov 5, 2021Granted 30,000 shares of Calithera Biosciences, Inc.7
- Oct 28, 2021Shares withheld for tax 45,965 shares at $1.89 of Calithera Biosciences, Inc.8
- Oct 27, 2021Granted 90,000 shares of Calithera Biosciences, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAN2 Therapeutics, Inc., Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jan 25, 2022
- 6SEC EDGARForm 4 filed Jan 6, 2022
- 7SEC EDGARForm 4 filed Nov 9, 2021
- 8SEC EDGARForm 4 filed Oct 29, 2021